Results 271 to 280 of about 289,373 (313)

Outcomes of intravascular brachytherapy for recurrent drug‐eluting in‐stent restenosis

Catheterization and cardiovascular interventions, 2020
To examine the outcomes of vascular brachytherapy (VBT) for recurrent drug‐eluting stents (DES) in‐stent restenosis (ISR).
M. Megaly, Matthew Glogoza, Iosif Xenogiannis, E. Vemmou, Ilias Nikolakopoulos, Laura Willson, D. Monyak, Patsa Sullivan, L. Stanberry, P. Sorajja, Ivan J. Chavez, M. Mooney, J. Traverse, Yale Wang, S. Garcia, A. Poulose, M. Burke, E. Brilakis   +17 more
semanticscholar   +1 more source

In-Stent Restenosis [PDF]

, 2018
Restenosis is an arterial wall healing response to mechanical injury at the site of a previously treated coronary segment. In-stent restenosis (ISR) is an angiographic diagnosis, defined as recurrent diameter stenosis >50% within a stent or at its edges (5 mm segments proximal and distal to the stent).
Roisin Colleran, Robert A. Byrne
openaire   +1 more source

In-stent restenosis in vertebral artery stenting [PDF]

Neuroradiology, 2007
Sir, Tsutsumi et al. reported the clinical and angiographic data on 12 patients receiving stent deployment for symptomatic ostial vertebral artery (VA) stenosis [1]. The in-stent re-stenosis (ISR) rate was surprising low – 0% angiographic restenosis at 12 months and 8% after a mean of 31.5 months clinical/radiological follow-up.
Yen-Hung Lin, Hsien-Li Kao
openaire   +2 more sources

Pathology of in-stent restenosis

Current Opinion in Lipidology, 1999
The process of in-stent restenosis parallels wound healing responses. Stent deployment results in early thrombus deposition and acute inflammation, granulation tissue development, and ultimately smooth muscle cell proliferation and extracellular matrix synthesis.
Renu Virmani, Andrew Farb
openaire   +3 more sources

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.

Journal of the American Medical Association (JAMA)
Importance Drug-coated balloons offer a potentially beneficial treatment strategy for the management of coronary in-stent restenosis. However, none have been previously evaluated or approved for use in coronary circulation in the United States ...
Robert W. Yeh, R. Shlofmitz, Jeffrey Moses, W. Bachinsky, S. Dohad, Steven G. Rudick, R. Stoler, Brian K. Jefferson, William J. Nicholson, John D. Altman, Cinthia T. Bateman, Amar Krishnaswamy, J. Grantham, Frank J. Zidar, S. Marso, J. Tremmel, Cindy Grines, Mustafa I. Ahmed, A. Latib, Behnam N. Tehrani, J. Abbott, Wayne B. Batchelor, Paul Underwood, Dominic Allocco, Ajay J. Kirtane, R. Shlofmitz, Jeffrey Moses, W. Bachinsky, S. Dohad, Steven G. Rudick, R. Stoler, Brian K. Jefferson, William J. Nicholson, John D. Altman, Robert W. Yeh, Cinthia T. Bateman, Amar Krishnaswamy, J. Grantham, Frank J. Zidar, Rajendran Sabapathy, J. Tremmel, Cindy Grines, Mustafa I. Ahmed, A. Latib, Behnam N. Tehrani, K. Alaswad, Carey Kimmelstiel, William Dixon, Arthur Reitman, Lawrence Ang, Justin Levisay, J. Abbott, Kathleen E. Kearney, F. Jaffer, Saroj Neupane, Kevin Croce, K. Shunk, Angela Taylor, Matthew Saybolt, Claro Diaz, Alpesh Shah, K. Lotun, Johannes Brechtken, Himanshu Agarwal, Rajan Patel   +64 more
semanticscholar   +1 more source

Treatment of coronary in-stent restenosis: a systematic review

Journal of Geriatric Cardiology, 2018
Coronary stent implantation has significantly improved percutaneous coronary intervention and enabled the management of early complications of plain balloon angioplasty. However, a new complication has accompanied these improvements: in-stent restenosis (
L. Pleva, Pavel Kukla, O. Hlinomaz
semanticscholar   +1 more source

Phantom Study of In-Stent Restenosis at High-Spatial-Resolution CT.

Radiology, 2018
Purpose To examine the diagnostic performance of high-spatial-resolution (HSR) CT with 0.25-mm section thickness for evaluating renal artery in-stent restenosis.
H. Onishi, M. Hori, T. Ota, A. Nakamoto, K. Osuga, M. Tatsumi, H. Fukui, S. Tsukagoshi, Ayumi Uranishi, Y. Saito, Akira Taniguchi, Y. Enchi, Kazuhiko Sato, N. Tomiyama   +13 more
semanticscholar   +1 more source

Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis

Circulation. Cardiovascular Interventions, 2018
Background: Because of the widespread acceptance of percutaneous coronary intervention with drug-eluting stents as an effective treatment strategy for in-stent restenosis, it is common to encounter multimetal layer stent restenosis in the recent years ...
M. Varghese, Samit Bhatheja, U. Baber, Safwan Kezbor, Aditi Chincholi, Surbhi Chamaria, M. Buckstein, R. Bakst, A. Kini, Samin K. Sharma   +9 more
semanticscholar   +1 more source

In-stent Restenosis of drug-eluting Stents

Future Cardiology, 2013
Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic ...
Ron Waksman, Augusto D. Pichard, Sa'ar Minha   +2 more
openaire   +2 more sources

The effectiveness of excimer laser angioplasty to treat coronary in-stent restenosis with peri-stent calcium as assessed by optical coherence tomography.

EuroIntervention, 2017
AIMS We aimed to evaluate the effectiveness of excimer laser coronary angioplasty (ELCA) to treat in-stent restenosis (ISR) due to peri-stent calcium-related stent underexpansion as assessed by optical coherence tomography (OCT). METHODS AND RESULTS We
Tetsumin Lee, R. Shlofmitz, Lei Song, Theofanis Tsiamtsiouris, T. Pappas, Antonio Madrid, A. Jeremias, E. Haag, Z. Ali, J. Moses, M. Matsumura, G. Mintz, A. Maehara   +12 more
semanticscholar   +1 more source